Multicenter Phase I Study of Erdafitinib (JNJ-42756493), Oral Pan-Fibroblast Gro

Discussion Board › Forums › Clinical Trials › Multicenter Phase I Study of Erdafitinib (JNJ-42756493), Oral Pan-Fibroblast Gro

Viewing 1 post (of 1 total)
  • Author
    Posts
  • May 16, 2019 at 3:41 am #98626
    gavin
    Moderator

    Multicenter Phase I Study of Erdafitinib (JNJ-42756493), Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients with Advanced or Refractory Solid Tumors.

    https://www.ncbi.nlm.nih.gov/pubmed/31088831

  • Author
    Posts
Viewing 1 post (of 1 total)
  • The forum ‘Clinical Trials’ is closed to new topics and replies.